Pursuant to section 35(1)(a) of the Medicines Act 1981, the Minister of Health hereby revokes consent to the distribution in New Zealand of the following medicines on 1 August 2010:
Product: Capadex
Active Ingredients: Dextropropoxyphene hydrochloride 32.5mg
Paracetamol 325mg
Dosage Form: Powder filled capsule
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited trading as Healthcare Logistics
Product: Paradex
Active Ingredients: Dextropropoxyphene napsilate monohydrate 50mg
Paracetamol 325mg
Dosage Form: Tablet
New Zealand Sponsor: PSM Healthcare Limited trading as SPI Consumer Brands
Dated this 3rd day of June 2010.
STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 20 December 2001 and the Director-General of Health on 18 January 2002).